Cart is empty Botulinum toxin-A (BTX), also known as Botox, is used to treat a range of neuromuscular disorders, including muscle spasms, dystonia, eye twitching, overactive bladder, and spasticity associated with cerebral palsy or stroke. Notably, BTX has gained popularity in cosmetology owing to its effectiveness in minimizing facial wrinkles. BTX works by inducing paralysis at neuromuscular junctions (NMJs)—the connections between a neuron (brain cell) and a muscle fiber.
Study identifies urgent need for improved research on how to respond to misleading health information
A study by researchers at the Brown University School of Public Health on ways to mitigate the impacts of misleading COVID-19 information found that variations in the designs of prior studies have complicated efforts at drawing strong conclusions about what worked and what did not.
Research investigates music’s effects on cells with implications for diabetes treatment
Could music affect cells? According to a recent life science project, it is possible. The results may be a first step to using music to treat diabetes.
Study sheds light on sporadic early-onset Alzheimer’s disease, potential target for novel treatment
Alzheimer’s disease (AD), the most prevalent neurodegenerative disease globally, poses a significant threat to human health. Most AD patients are diagnosed after the age of 65, categorized as late-onset AD (LOAD). However, about 5%–10% of AD patients show symptoms before the age of 65, exhibiting the same pathological characteristics as AD, classified as early-onset AD (EOAD).
Nanoplastics promote conditions for Parkinson’s across various lab models, study shows
Nanoplastics interact with a particular protein that is naturally found in the brain, creating changes linked to Parkinson’s disease and some types of dementia.
Exploring the environmental and monetary benefits of redispensing cancer pills
Redispensing cancer drugs reduces both environmental impact and medical costs, according to research from Radboudumc pharmacy published in JAMA Oncology. The annual savings could amount to tens of millions.
Study shows amount and days of opioids prescribed at discharge decreased after 2017 Ohio prescription opioid cap law
The Ohio Opioid Cap Law, enacted on August 31, 2017, limited the total dose and duration of opioids that could be prescribed for minors. The anticipated benefit of cap laws in preventing opioid overdose, death and addiction was counterbalanced by fears that decreased opioid prescribing could hurt patient satisfaction.
Study shows beach signage education could save lives this summer
A new beach safety study aims to prevent accidental beach drownings of young people through the identification of their understanding—and misunderstanding—of common beach signs.
What leads people to take action on disease prevention?
When making important decisions about disease prevention, who do you listen to? Medical institutions? Or perhaps the people around you? Your answer might reveal more about your personal circumstances than you would expect.
Study identifies the top three genes responsible for traumatic brain injury complications
The severity of traumatic brain injury (TBI) has been underscored in the last decade as doctors seek to understand its role in neurological diseases like chronic traumatic encephalopathy (CTE), a progressive and fatal brain disorder caused by repeated head injury that gained notoriety for its markedness among NFL pros including Mike Webster and Aaron Hernandez.